- Country: USA
- Summary: Research Laboratory Services for DNA Testing Reducing Veterans Risk of Atherosclerotic Cardiovascular Disease Through Pharmacogenomics Informed Statin Prescribing
- UST Ref No: 112174663
- Deadline: 06 Jan 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 36C24E25Q0023
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
SOURCES SOUGHT NOTICE Sources Sought: This is NOT a solicitation for a proposal, proposal abstract, or quote. The purpose of this notice is to obtain information regarding qualified business sources. The responses to the information requested will assist the Government in determining the appropriate acquisition method.STATEMENT OF WORK (SOW)The Contractor shall render genetic testing laboratory services in accordance with this Statement of Work to support the Health Science Research Department at Durham VA Medical Center under the direction of Dr. Deepak Voora, Executive Director of National Pharmacogenomics Program at VA Central Office, for the study/IIR titled, Reducing Veterans' Risk of Atherosclerotic Cardiovascular Disease Through Pharmacogenomics Informed Statin Prescribing funded by the VA Durham Healthcare System and delivered to the Indianapolis VA Health Care System.Description: Genomic medicine research has many complexities requiring specialized services, skills, and expertise, including complex laboratory analyses requiring specialized equipment and expertise in the generation and interpretation of genomic data; large complex genomic datasets with particular storage, privacy, and information security requirements; clinical expertise in how genomic medicine interventions might inform health care and impact health outcomes; and sensitivity to the ethical, psychosocial, legal, and regulatory considerations of genomic medicine research. Background: This research grant proposes a single center, randomized clinical trial of precision statin prescribing versus usual care to be conducted at the Indianapolis VA Health Care System. Four-hundred and ten (410) Veteran patients who are at risk for cardiovascular events and have a Class I indication for statin therapy, but are not currently prescribed one, will be recruited and randomly allocated to receive either 1) genetic test report that provides an assessment of their risk for cardiovascular dise... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINResearch Laboratory Services for DNA Testing Reducing Veterans Risk of Atherosclerotic Cardiovascular Disease Through Pharmacogenomics Informed Statin Prescribing - USA Tender
The VETERANS AFFAIRS, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Research Laboratory Services for DNA Testing Reducing Veterans Risk of Atherosclerotic Cardiovascular Disease Through Pharmacogenomics Informed Statin Prescribing. This tender is published on USARFP under UST Ref No: 112174663 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-01-06.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
